{"news_desk": "Business", "print_page": "4", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Turing Pharmaceuticals announces it will not reduce list price on drug Daraprim, two months after company faced public criticism for sharply increasing price of drug and statements by its chief executive Martin Shkreli that company would reduce price.", "type_of_material": "News", "word_count": "540", "lead_paragraph": "Daraprim costs $750 a tablet. Though Turing Pharmaceuticals said it will cut the price for hospitals and patients with commercial health insurance, some doctors say it isn\u2019t enough.", "pub_date": "2015-11-25T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Turing Refuses to Lower List Price of Toxoplasmosis Drug", "print_headline": "Maker of $750-a-Pill Drug Refuses to Lower List Price "}, "snippet": "Daraprim costs $750 a tablet. Though Turing Pharmaceuticals said it will cut the price for hospitals and patients with commercial health insurance, some doctors say it isn\u2019t enough.", "multimedia": [{"height": 126, "url": "images/2015/11/24/business/1125shkrelijpg/1125shkrelijpg-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/24/business/1125shkrelijpg/1125shkrelijpg-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 293, "url": "images/2015/11/24/business/1125shkrelijpg/1125shkrelijpg-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "293", "xlarge": "images/2015/11/24/business/1125shkrelijpg/1125shkrelijpg-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/24/business/1125shkrelijpg/1125shkrelijpg-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/24/business/1125shkrelijpg/1125shkrelijpg-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/25/business/turing-refuses-to-lower-list-price-of-toxoplasmosis-drug.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "4", "is_major": "N", "value": "Acquired Immune Deficiency Syndrome", "name": "subject"}], "blog": [], "_id": "56550f9238f0d80209d5af17", "source": "The New York Times"}